← Mechanisms of action
D2-like dopamine receptor
PROTEIN FAMILYHomo sapiens
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| apomorphine (apokyn) | Agonist | approved | Small molecule | D2-like dopamine receptor agonist |
| bromocriptine (parlodel) | Agonist | approved | Small molecule | D2-like dopamine receptor agonist |
| pramipexole (mirapex) | Agonist | approved | Small molecule | D2-like dopamine receptor agonist |
| ropinirole (Requip) | Agonist | approved | Small molecule | D2-like dopamine receptor agonist |
| rotigotine (neupro) | Agonist | approved | Small molecule | D2-like dopamine receptor agonist |
| chlorpromazine (Thorazine) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| droperidol (innovar) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| levomepromazine (levoprome) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| loxapine (loxitane) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| olanzapine (zyprexa) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| promazine hydrochloride (sparine) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| thioridazine (mellaril) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| trifluoperazine (stelazine) | Antagonist | approved | Small molecule | D2-like dopamine receptor antagonist |
| haloperidol (haldol) | Inverse agonist | approved | Small molecule | D2-like dopamine receptor inverse agonist |